Literature DB >> 4562479

Fermentation process for double-stranded ribonucleic acid, an interferon inducer.

B D Lago, J Birnbaum, A L Demain.   

Abstract

Double-stranded ribonucleic acid (ds-RNA) isolated from Escherichia coli infected with bacteriophage MS2 is a potent interferon inducer. High levels of ds-RNA are formed in nonpermissive cells infected with MU9, an amber coat protein mutant of MS2. This mutant has been used to develop a process for large-scale ds-RNA production. Preparation of quantities of MU9 lysate sufficient for ds-RNA production in fermentors is described. Over 300 mug of ds-RNA/ml can be accumulated after MU9 infection of cultures grown to high density in corn steep liquor medium. This is approximately 300 times the amount of ds-RNA made by MS2 infection of cells grown in tryptone medium. Maximum ds-RNA formation requires only 3 hr. The ds-RNA is stable and remains inside nonaerated cells for at least 17 hr.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4562479      PMCID: PMC376536          DOI: 10.1128/am.24.3.430-436.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  17 in total

1.  Inducers of interferon and host resistance, IV. Double-stranded replicative form RNA (MS2-Ff-RNA) from E. coli infected with MS2 coliphage.

Authors:  A K Field; G P Lampson; A A Tytell; M M Nemes; M R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-11       Impact factor: 11.205

2.  Virus-specific proteins in Escherichia coli infected with some amber mutants of phage MS2.

Authors:  E Viñuela; I D Algranati; G Feix; D Garwes; C Weissmann; S Ochoa
Journal:  Biochim Biophys Acta       Date:  1968-02-26

3.  Cell lysis: another function of the coat protein of the bacteriophage f2.

Authors:  N D Zinder; L B Lyons
Journal:  Science       Date:  1968-01-05       Impact factor: 47.728

4.  Stages in phage R17 infection: the role of divalent cations.

Authors:  W Paranchych
Journal:  Virology       Date:  1966-01       Impact factor: 3.616

5.  Functions of F pili in mating-pair formation and male bacteriophage infection studies by blending spectra and reappearance kinetics.

Authors:  C Novotny; E Raizen; W S Knight; C C Brinton
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

Review 6.  The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria.

Authors:  C C Brinton
Journal:  Trans N Y Acad Sci       Date:  1965-06

7.  Suppressor genes for nonsense mutations. I. The Su-1, Su-2 and Su-3 genes of Escherichia coli.

Authors:  A Garen; S Garen; R C Wilhelm
Journal:  J Mol Biol       Date:  1965-11       Impact factor: 5.469

8.  Isolation and characterization of amber mutants of bacteriophage R17.

Authors:  J Tooze; K Weber
Journal:  J Mol Biol       Date:  1967-09-14       Impact factor: 5.469

9.  Mutants of the bacteriophage f2. 8. Control mechanisms for phage-specific syntheses.

Authors:  H F Lodish; N D Zinder
Journal:  J Mol Biol       Date:  1966-08       Impact factor: 5.469

10.  New procedures for purification of L-asparaginase with high yield from Escherichia coli.

Authors:  J Roberts; G Burson; J M Hill
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

View more
  3 in total

1.  DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli.

Authors:  Yamei Liu; Victor G Stepanov; Ulrich Strych; Richard C Willson; George W Jackson; George E Fox
Journal:  BMC Biotechnol       Date:  2010-12-06       Impact factor: 2.563

2.  Professor Arnold L. (Arny) Demain's historical position in the rise of industrial microbiology and biotechnology.

Authors:  Erick J Vandamme
Journal:  J Ind Microbiol Biotechnol       Date:  2021-12-23       Impact factor: 4.258

3.  RNA: packaged and protected by VLPs.

Authors:  Po-Yu Fang; Jessica C Bowman; Lizzette M Gómez Ramos; Chiaolong Hsiao; Loren Dean Williams
Journal:  RSC Adv       Date:  2018-06-12       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.